Incyte

United Therapeutics

Gilead Sciences

Natera

Neurocrine Biosciences

Alnylam Pharmaceuticals

Vertex Pharmaceuticals

Insmed

Sarepta Therapeutics

Viking Therapeutics

SPDR S&P Biotech ETF

XBI tracks an equal-weighted index of US biotechnology stocks.

Exelixis

Immunomedics

Breakouts beyond key levels of resistance suggest that the bulls are in control of the momentum in the biotech sector.

3 Charts That Suggest Biotech Stocks Are Headed Higher

Loncar Cancer Immunotherapy ETF

iShares Nasdaq Biotechnology ETF

U.S. stocks are continuing to soar higher on Monday, moving into positive territory for May, following news that drugmaker Moderna released positive, preliminary results from the first human trial of its experimental Covid-19 vaccine, generating optimism that the medical community was taking steps to beat the coronavirus. Shares of the biotech company soared surged over [.

Biotech ETFs Climbing As Moderna Builds Hope For Coronavirus Vaccine

VanEck Vectors Biotech ETF

Positive data on early-stage coronavirus vaccine trial sent Moderna shares surging.

Moderna Soars: Biotech ETFs in Focus

Biotechnology-themed exchange-traded funds surged higher late Monday morning as investors rewarded pharmaceutical companies that looked likely to profit from treatments for COVID-19.

Biotech ETFs trade higher on upbeat coronavirus results

VanEck Vectors Pharmaceutical ETF

Invesco DWA Healthcare Momentum ETF

Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.

3 ETFs in Focus as Race for Vaccine Intensifies

Invesco Dynamic Biotechnology & Genome ETF

The rising incidence of cancer cases has encouraged several major pharmaceutical and biotech players to invest substantially in the developments of drugs.

Biotech ETFs to Gain From Latest Advancements in Cancer Drugs

iShares MSCI Emerging Markets ETF

iShares iBoxx High Yield Corporate Bond ETF

iShares Russell 2000 ETF

Invesco QQQ

SPDR S&P 500 ETF Trust

The S&P 50o has come roaring back in the past two months, but there are still plenty of skeptics when it comes to the recent rally.

ETF Short Sellers Are Targeting Retail, Biotech

Virtus LifeSci Biotech Clinical Trials ETF

Biotechnology sector-related exchange traded funds led the charge on Monday, with some breaking out to new highs. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution ETF (CBOE: ARKG) jumped 6.1% and Virtus LifeSci Biotech Clinical Trials ETF (BBC) surged 6.4%.

Biotechnology Sector ETFs Are Leading the Charge

Biotech ETF XBI among the top performing ETFs this week in terms of fund flows.  Rebound in flows to US large-cap ETFs may portend a continuation of the current rally.

Biotech ETF XBI Among Top Performers

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q1 earnings releases amid the coronavirus crisis.

Are Biotech ETFs in Trouble as Coronavirus Dims Guidance?

Rising investor interest in coronavirus related stocks will benefit these ETFs

Biotech ETFs Poised to Benefit From Coronavirus

Invesco DWA Technology Momentum ETF

SPDR S&P Oil & Gas Exploration & Production ETF

After a wobbly start, Wall Street steadied in May. These sector ETFs contributed the most in Wall Street recovery on Monday.

3 Sector ETFs Gaining Momentum in May

The coronavirus outbreak is prompting investors to visit the healthcare sector, a trend that could benefit ETFs, including the SPDR S&P Biotech ETF (NYSEArca: XBI). XBI, one of the largest biotechnology ETFs by assets, uses an equal-weight methodology, meaning it tilts toward smaller companies, but not at the expense of exposure to some of the [.

How a Popular Biotech ETF Fits Into the Coronavirus Investing Landscape

Strong gains in April pushed the health care sector near year highs on hopes for new Covid treatments.

Investor hope pushes biotech stocks to best monthly gain in two decades

Alerian MLP ETF

ETRACS Alerian MLP Index ETN

InfraCap MLP

Principal Healthcare Innovators Index ETF

First Trust Natural Gas ETF

U.S. Global GO GOLD and Precious Metal Miners ETF

Global X Gold Explorers ETF

Amplify Online Retail ETF

Global X MLP ETF

ON Semiconductor

iShares MSCI Global Gold Miners ETF

Sprott Gold Miners ETF

These ETF areas showered gains in the lockdown-infected April.

5 Top-Performing ETF Areas of April That Are Up At Least 25%

As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.

Biotech ETFs Gain on New Positive Data for Gilead's Remdesivir

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.

Healthcare ETFs to Gain on Progress in Coronavirus Vaccine

First Trust Large Cap Growth AlphaDEX Fund

iSh Mrng Md-CG Shs

Invesco Dynamic Semiconductors ETF

Vanguard Consumer Discretionary ETF

SPDR S&P Internet ETF

With the start of the second quarter, the U.S. stock markets have regained momentum on easing coronavirus pandemic as well as unprecedented fiscal and monetary stimulus.

6 Top-Ranked ETFs Beating the Market

First Trust NYSE Arca Biotechnology Index Fund

iShares U.S. Healthcare Providers ETF

Invesco Dynamic Pharmaceuticals ETF

Coronavirus Sparked Healthcare ETFs In General, But Ultimately, We Really Do Need To Pick And Choose

Abbott Labs

Johnson & Johnson

Moderna

Regeneron Pharmaceuticals

In this episode of ETF Spotlight, I speak with biotech expert Brad Loncar, about latest developments in coronavirus testing, vaccines and treatments.

Coronavirus Testing, Vaccines & Treatments: What You Should Know

S&P Biotech ETF (XBI) slumped -20% year-to-date, in-line with the S&P 500, due to the unrelenting coronavirus pandemic,.

XBI: Biotech ETF Expected To Outperform During And After The Coronavirus Pandemic

AbbVie

Amgen

Biogen

Bristol-Myers

Novartis

Pfizer

Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.

4 Reasons Drug Stocks Are a Buy Right Now

SPDR S&P Retail ETF

Retail stocks are getting pummeled as the coronavirus outbreak worsens in the United States and swaths of the country enter a lockdown. Ari Wald of Oppenheimer breaks down the charts.

Retail is having its worst month ever, and chart analyst warns against buying on weakness

Fidelity MSCI Information Technology Index ETF

Schwab U.S. Large-Cap Value ETF

Materials Select Sector SPDR Fund

Grab these ETFs that have a solid Zacks Rank and are available at extremely low prices. These funds have a low expense ratio too.

5 Low-Cost Top-Ranked ETFs to Tap at Discounted Prices

Technology Select Sector SPDR Fund

XLK and XBI saw massive trading volumes in yesterday trading.

News for SPDR S&P Biotech ETF ETF (XBI)